Literature DB >> 29115029

Kawasaki disease: epidemiology and the lessons from it.

Yosikazu Nakamura1.   

Abstract

A half of century has passed since Dr. Tomisaku Kawasaki reported his 50 cases with Kawasaki disease (KD) in 1967. Since then, more than 300 000 cases have been reported to the nationwide epidemiologic surveys in Japan. However, the etiology and risk factors of the disease are still unknown. In this paper, the author emphasizes that the epidemiology of KD may indicate an infectious agent to be a potential trigger of disease in susceptible children.
© 2017 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  epidemics; epidemiology; etiology; mucocutaneous lymph node syndrome; risk factors

Mesh:

Year:  2017        PMID: 29115029     DOI: 10.1111/1756-185X.13211

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  21 in total

Review 1.  [CT Imaging Findings in Non-Atherosclerotic Coronary Artery Disease].

Authors:  Jongmin Park; Byunggeon Park; Eun-Ju Kang; Jongmin Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2022-01-21

2.  Is multisystem inflammatory syndrome in children on the Kawasaki syndrome spectrum?

Authors:  Rae Sm Yeung; Polly J Ferguson
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

3.  COVID-19-related Multisystem Inflammatory Syndrome in a Young Adult.

Authors:  Francisco Pombo; Carolina Seabra; Vergilio Soares; Ana João Sá; Inês Ferreira; Marina Mendes
Journal:  Eur J Case Rep Intern Med       Date:  2021-04-19

4.  Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome.

Authors:  Pedram Keshavarz; Fereshteh Yazdanpanah; Sara Azhdari; Hadiseh Kavandi; Parisa Nikeghbal; Amir Bazyar; Faranak Rafiee; Seyed Faraz Nejati; Faranak Ebrahimian Sadabad; Nima Rezaei
Journal:  J Med Virol       Date:  2021-05-24       Impact factor: 20.693

Review 5.  Perspective of Immunopathogenesis and Immunotherapies for Kawasaki Disease.

Authors:  Lung Chang; Horng-Woei Yang; Tang-Yu Lin; Kuender D Yang
Journal:  Front Pediatr       Date:  2021-07-19       Impact factor: 3.418

6.  The Blood Gene Expression Signature for Kawasaki Disease in Children Identified with Advanced Feature Selection Methods.

Authors:  Bing Hu; Yun Li; Guilian Wang; Yanqing Zhang
Journal:  Biomed Res Int       Date:  2020-06-28       Impact factor: 3.411

7.  Differences over 10 years in epidemiologic and clinical features of Kawasaki disease at a single tertiary center.

Authors:  Hyun Su Kim; Suk Won Shin; Bo Geum Choi; Hee Joung Choi
Journal:  Clin Exp Pediatr       Date:  2020-02-05

8.  Observation on the clinical effect of high-dose Intravenous Immunoglobulin combined with low-dose prednisone acetate in the treatment of patients with Kawasaki Disease.

Authors:  Hao Zhang; Mei-Ying Wang; Yong-Nan Teng; Xiao-Dan Wang; Hai-Tao Cao
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

9.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Authors:  Lucio Verdoni; Angelo Mazza; Annalisa Gervasoni; Laura Martelli; Maurizio Ruggeri; Matteo Ciuffreda; Ezio Bonanomi; Lorenzo D'Antiga
Journal:  Lancet       Date:  2020-05-13       Impact factor: 79.321

10.  Kawasaki disease epidemic: pitfalls.

Authors:  Romina Gallizzi; Giovanni Corsello; Giovanni Battista Pajno
Journal:  Ital J Pediatr       Date:  2020-08-27       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.